Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Dr. R Ananthanarayanan appointed as the new CEO & Managing Director of Strides

Posted On: 2020-01-08 20:48:27

Strides Pharma Science Limited (Strides) today announced that the Board of Directors (Board) of the Company have appointed Dr. R Ananthanarayanan as Chief Executive Officer (CEO) and Managing Director (MD) of Strides effective January 09, 2020.

Dr. R Ananthanarayanan (Ananth) will succeed Arun Kumar, Founder, and the incumbent CEO & MD of the Company. Arun will transition his active responsibilities at Strides by the financial year ending March 31, 2020, and will step into a strategic role as Chairman of the Board with effect from April 01, 2020.

Ananth brings with him over three decades of top pedigree global pharmaceutical experience across both the technical and commercial functions. Until recently, Ananth was the Global Chief Operating Officer at Cipla Limited, where he was responsible for the company's generics business in regulated markets and branded generics in emerging markets. He was also driving their API business, biosimilars, complex drug-device combinations, including 505(b)(2) products.

Prior to Cipla, Ananth was the President & CEO of Global APIs, Biologics, & Medis Generics B2B division at Teva Pharmaceutical Industries Ltd in the US, managing multi-billion P&L responsibility. He has also held leadership roles at Dr. Reddy's Laboratories, Piramal Healthcare (Formerly Nicholas Piramal), Galpharm International, UK (Acquired by Perrigo Group), and Zydus Cadila.

Ananth is a Graduate in Pharmaceutical Sciences and earned his Ph.D. in Pharmaceutical Technology from the University of Mumbai, India. He has also been a member of the Board of Advisors at the School of Pharmacy and Health Sciences at Fairleigh Dickinson University, New Jersey.

Ananth's appointment at Strides comes at the time when the company has concluded its reset strategy to drive profitable future growth on the back of a stronger balance sheet. The Board strongly believes that Ananth's exceptional global techno-commercial experience and leadership stature in managing the P&Ls of large global pharmaceutical companies will multiply the company's commitment to creating perpetual value for all its stakeholders.

Expressing confidence in the Board's choice , Arun Kumar,remarked, "Having founded Strides and led the company for close to 30 years, I believe the time is right for me to step aside and have Ananth lead it to greater heights. Ananth brings in the right balance of technical and commercial expertise, and I am confident that Strides will significantly benefit from his leadership experience, industry perspective, technical knowledge, and business acumen. As he takes on the mantle of Strides, I will now move to a more strategic role as the Chairman of the Board and will dedicate time to Strides' newly announced investments in Biotech and sterile injectables."

Dr. R Ananthanarayanan, the new CEO & MD of Strides, commented, "It's my privilege and honor to take over as the CEO & MD of Strides, and I would like to appreciate the confidence reposed in me by Arun and the Board. These are exciting times for Strides, and I look forward to partner with all the global colleagues to ensure successful realization of the Strides strategic objectives while ensuring that we consistently deliver quality medicines to all our patients globally."

Shares of Strides Pharma Science Ltd was last trading in BSE at Rs.382 as compared to the previous close of Rs. 375.4. The total number of shares traded during the day was 58063 in over 1374 trades.

The stock hit an intraday high of Rs. 382 and intraday low of 369.2. The net turnover during the day was Rs. 21780724.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

IIFL Wealth Management Ltd board declares interim dividend of Rs. 10 for FY 2019-20

IIFL Wealth Management Ltd consolidated Q3 net profit at Rs. 74.15 crore

Piramal Enterprises Limited Rights Issue Over-Subscribed ~1.14 Times

Syngene appoints Jonathan Hunt as Managing Director and Chief Executive Officer

Clarifications on Demand Notice received from DoT on AGRDues

Cipla Ltd updates on USFDA inspection at Goa facility

Cignex Datamatics and Relevance Lab deal not approved by DGSL shareholders; revised terms in discussions

Ujjivan Small Finance Bank Ltd reports Q3 FY2019-20 financial performance

CEAT EBITDA rises in Q3 FY19-20, stands at INR 188 crore

IndiGrid Q3 EBITDA up by 102% YoY

L&T announces Q3 FY2019-20 results

AU Small Finance Bank Ltd Q3 PAT climbs to Rs. 190.19 crore

AXISCADES Engineering Technologies Ltd consolidated net profit at Rs. 8.02 crore in Q3

PRO FIN Capital Services Ltd Q3 consolidated PAT at Rs. 0.82 crore

Raymond Ltd consolidated Q3 PAT at Rs. 195.28 crore

Ozone World Ltd Q3 net profit at Rs. 0.11 crore

Syngene International Ltd reports consolidated Q3 PAT of Rs. 91.8 crore

Victory Paper & Boards India Ltd posts loss in Q3 FY20

Agro Tech Foods Ltd Q3 consolidated net profit declines to Rs. 7.50 crore

Supreme Petrochem Ltd reports net profit of Rs. 2.07 crore in Q3

Cigniti Technologies Ltd Q3 consolidated net profit slips to Rs. 28.11 crore

AXIS Bank Ltd posts Q3 FY20 consolidated PAT of Rs. 1884 crores

CreditAccess Grameen Ltd reports net profit of Rs. 107.99 crore in Q3

Genus Power Infrastructures Ltd consolidated net profit drops to Rs. 16.83 crore in Q3

Ashirwad Capital Ltd Q3 FY20 net profit at Rs. 0.0632 crore

RBL Bank Ltd reports consolidated net profit of Rs. 66.49 crore in Q3

TATA Communications Ltd Q3 consolidated net profit drops YoY

CEAT Ltd consolidated Q3 net profit up at Rs. 52.79 crore

SBI Life Insurance Company Ltd posts Rs. 389.77 crore PAT in Q3

Jindal Drilling & Industries Ltd commences operation rig 'VIRTUE 1'

Solitaire Machine Tools Ltd allotted plot by GIDC

Sharda Cropchem Ltd Board declares Interim Dividend of Rs. 2 for 2019-20

Ashiana Housing Ltd obtains RERA registration for Phase 1 of 'Ashiana Amantran'

HUDCO updates on business in 2019-20

Frontline Corporation Ltd executes target letter of Rs. 26 crores with Bosch Ltd

Motilal Oswal Financial Services Ltd board declares interim dividend of Rs. 4

Ind-Ra affirms Cipla's long-term issuer rating

Man lnfraconstruction Ltd receives LoA for work worth Rs. 78.83 Crore from Indian Port Rail & Ropeway Corporation Limited

Businesses Face a Digital Ceiling in their Transformation Progress, Infosys Digital Radar Reveals

C Vijayakumar, CEO, HCL Technologies Named Chairman of World Economic Forum's IT Governors Community

TCS Consolidates its Growth and Transformation Brand Leadership

Edelweiss Finance & Investments Limited announces Public Issue of Secured Redeemable NCDs amounting to Rs 250 crores

HKG Ltd launches www.funkymobile.in

Sharda Cropchem Ltd Q3 consolidated PAT at Rs. 5.85 crore

VST Industries Ltd posts PAT of Rs. 81.48 crores in Q3

Motilal Oswal Financial Services Ltd Q3 consolidated net profit jumps to Rs. 165.44 crore

Alchemist Corporation Ltd Q3 net profit at Rs. 0.07 crore

Alembic Pharmaceuticals Ltd Q3 consolidated PAT at Rs. 234.19 crore

Asian Paints Ltd consolidated Q3 net profit drops QoQ

Gateway Distriparks Ltd consolidated Q3 net profit at Rs. 16.51 crore







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019